The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
HIV Diagnosis & Treatment-Global Market Insights and Sales Trends 2024
Synopsis
HIV prevalence in Africa, specifically in Southern region is very high as compared to North African region. Approximately 1 out of 4 is suffering from HIV. Southern and Eastern region of Africa has one of the highest prevalence rate of HIV, about 19 million people have HIV. While HIV prevalence is low in North Africa but the number of cases of HIV are increasing rapidly. There is no cure for HIV but drugs manufacturing companies are investing huge money in R&D to develop drugs for HIV.
The global HIV Diagnosis & Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of HIV Diagnosis & Treatment in various end use industries. The expanding demands from the Hospitals and Clinics, are propelling HIV Diagnosis & Treatment market. ELISA Test, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Saliva Tests segment is estimated at % CAGR for the next seven-year period.
Over 3000 patients were died in sub Saharan Africa due to HIV in 2015. Following 10 countries from Africa consists of 80% of total HIV burden which are South Africa, Kenya, Malawi, Ethiopia, Mozambique, United Republic of Tanzania, Nigeria, Uganda, Zimbabwe and Zambia.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for HIV Diagnosis & Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global HIV Diagnosis & Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global HIV Diagnosis & Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, HIV Diagnosis & Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of HIV Diagnosis & Treatment covered in this report include Abbott Laboratories, Boehringer Ingelheim, Bristol-Myers Squibb, Cipla, F. Hoffmann-La Roche, Gilead, GlaxoSmithKline and Johnson & Johnson, etc.
The global HIV Diagnosis & Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Boehringer Ingelheim
Bristol-Myers Squibb
Cipla
F. Hoffmann-La Roche
Gilead
GlaxoSmithKline
Johnson & Johnson
Global HIV Diagnosis & Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global HIV Diagnosis & Treatment market, Segment by Type:
ELISA Test
Saliva Tests
Viral Load Test
Western Blot
Others
Global HIV Diagnosis & Treatment market, by Application
Hospitals
Clinics
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of HIV Diagnosis & Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
HIV prevalence in Africa, specifically in Southern region is very high as compared to North African region. Approximately 1 out of 4 is suffering from HIV. Southern and Eastern region of Africa has one of the highest prevalence rate of HIV, about 19 million people have HIV. While HIV prevalence is low in North Africa but the number of cases of HIV are increasing rapidly. There is no cure for HIV but drugs manufacturing companies are investing huge money in R&D to develop drugs for HIV.
The global HIV Diagnosis & Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of HIV Diagnosis & Treatment in various end use industries. The expanding demands from the Hospitals and Clinics, are propelling HIV Diagnosis & Treatment market. ELISA Test, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Saliva Tests segment is estimated at % CAGR for the next seven-year period.
Over 3000 patients were died in sub Saharan Africa due to HIV in 2015. Following 10 countries from Africa consists of 80% of total HIV burden which are South Africa, Kenya, Malawi, Ethiopia, Mozambique, United Republic of Tanzania, Nigeria, Uganda, Zimbabwe and Zambia.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for HIV Diagnosis & Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global HIV Diagnosis & Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global HIV Diagnosis & Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, HIV Diagnosis & Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of HIV Diagnosis & Treatment covered in this report include Abbott Laboratories, Boehringer Ingelheim, Bristol-Myers Squibb, Cipla, F. Hoffmann-La Roche, Gilead, GlaxoSmithKline and Johnson & Johnson, etc.
The global HIV Diagnosis & Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Boehringer Ingelheim
Bristol-Myers Squibb
Cipla
F. Hoffmann-La Roche
Gilead
GlaxoSmithKline
Johnson & Johnson
Global HIV Diagnosis & Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global HIV Diagnosis & Treatment market, Segment by Type:
ELISA Test
Saliva Tests
Viral Load Test
Western Blot
Others
Global HIV Diagnosis & Treatment market, by Application
Hospitals
Clinics
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of HIV Diagnosis & Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of HIV Diagnosis & Treatment
1.1 HIV Diagnosis & Treatment Market Overview
1.1.1 HIV Diagnosis & Treatment Product Scope
1.1.2 HIV Diagnosis & Treatment Market Status and Outlook
1.2 Global HIV Diagnosis & Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global HIV Diagnosis & Treatment Market Size by Region (2018-2029)
1.4 Global HIV Diagnosis & Treatment Historic Market Size by Region (2018-2023)
1.5 Global HIV Diagnosis & Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, HIV Diagnosis & Treatment Market Size (2018-2029)
1.6.1 North America HIV Diagnosis & Treatment Market Size (2018-2029)
1.6.2 Europe HIV Diagnosis & Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific HIV Diagnosis & Treatment Market Size (2018-2029)
1.6.4 Latin America HIV Diagnosis & Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa HIV Diagnosis & Treatment Market Size (2018-2029)
2 HIV Diagnosis & Treatment Market by Type
2.1 Introduction
2.1.1 ELISA Test
2.1.2 Saliva Tests
2.1.3 Viral Load Test
2.1.4 Western Blot
2.1.5 Others
2.2 Global HIV Diagnosis & Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global HIV Diagnosis & Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global HIV Diagnosis & Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America HIV Diagnosis & Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe HIV Diagnosis & Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific HIV Diagnosis & Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America HIV Diagnosis & Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa HIV Diagnosis & Treatment Revenue Breakdown by Type (2018-2029)
3 HIV Diagnosis & Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.2 Global HIV Diagnosis & Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global HIV Diagnosis & Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global HIV Diagnosis & Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America HIV Diagnosis & Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe HIV Diagnosis & Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific HIV Diagnosis & Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America HIV Diagnosis & Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa HIV Diagnosis & Treatment Revenue Breakdown by Application (2018-2029)
4 HIV Diagnosis & Treatment Competition Analysis by Players
4.1 Global HIV Diagnosis & Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in HIV Diagnosis & Treatment as of 2022)
4.3 Date of Key Players Enter into HIV Diagnosis & Treatment Market
4.4 Global Top Players HIV Diagnosis & Treatment Headquarters and Area Served
4.5 Key Players HIV Diagnosis & Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 HIV Diagnosis & Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories HIV Diagnosis & Treatment Products, Services and Solutions
5.1.4 Abbott Laboratories HIV Diagnosis & Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Laboratories Recent Developments
5.2 Boehringer Ingelheim
5.2.1 Boehringer Ingelheim Profile
5.2.2 Boehringer Ingelheim Main Business
5.2.3 Boehringer Ingelheim HIV Diagnosis & Treatment Products, Services and Solutions
5.2.4 Boehringer Ingelheim HIV Diagnosis & Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Boehringer Ingelheim Recent Developments
5.3 Bristol-Myers Squibb
5.3.1 Bristol-Myers Squibb Profile
5.3.2 Bristol-Myers Squibb Main Business
5.3.3 Bristol-Myers Squibb HIV Diagnosis & Treatment Products, Services and Solutions
5.3.4 Bristol-Myers Squibb HIV Diagnosis & Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Cipla Recent Developments
5.4 Cipla
5.4.1 Cipla Profile
5.4.2 Cipla Main Business
5.4.3 Cipla HIV Diagnosis & Treatment Products, Services and Solutions
5.4.4 Cipla HIV Diagnosis & Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Cipla Recent Developments
5.5 F. Hoffmann-La Roche
5.5.1 F. Hoffmann-La Roche Profile
5.5.2 F. Hoffmann-La Roche Main Business
5.5.3 F. Hoffmann-La Roche HIV Diagnosis & Treatment Products, Services and Solutions
5.5.4 F. Hoffmann-La Roche HIV Diagnosis & Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 F. Hoffmann-La Roche Recent Developments
5.6 Gilead
5.6.1 Gilead Profile
5.6.2 Gilead Main Business
5.6.3 Gilead HIV Diagnosis & Treatment Products, Services and Solutions
5.6.4 Gilead HIV Diagnosis & Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Gilead Recent Developments
5.7 GlaxoSmithKline
5.7.1 GlaxoSmithKline Profile
5.7.2 GlaxoSmithKline Main Business
5.7.3 GlaxoSmithKline HIV Diagnosis & Treatment Products, Services and Solutions
5.7.4 GlaxoSmithKline HIV Diagnosis & Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 GlaxoSmithKline Recent Developments
5.8 Johnson & Johnson
5.8.1 Johnson & Johnson Profile
5.8.2 Johnson & Johnson Main Business
5.8.3 Johnson & Johnson HIV Diagnosis & Treatment Products, Services and Solutions
5.8.4 Johnson & Johnson HIV Diagnosis & Treatment Revenue (US$ Million) & (2018-2023)
5.8.5 Johnson & Johnson Recent Developments
6 North America
6.1 North America HIV Diagnosis & Treatment Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe HIV Diagnosis & Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific HIV Diagnosis & Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America HIV Diagnosis & Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa HIV Diagnosis & Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 HIV Diagnosis & Treatment Market Dynamics
11.1 HIV Diagnosis & Treatment Industry Trends
11.2 HIV Diagnosis & Treatment Market Drivers
11.3 HIV Diagnosis & Treatment Market Challenges
11.4 HIV Diagnosis & Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
